Liaw YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol. 2009;51:403–10.

Article  PubMed  Google Scholar 

Moucari R, Korevaar A, Lada O, Martinot-Peignoux M, Boyer N, Mackiewicz V, Dauvergne A, Cardoso AC, Asselah T, Nicolas-Chanoine MH, et al. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study. J Hepatol. 2009;50:1084–92.

Article  CAS  PubMed  Google Scholar 

Kim GA, Lim YS, An J, Lee D, Shim JH, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability. Gut. 2014;63:1325–32.

Article  CAS  PubMed  Google Scholar 

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr., Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.

Article  PubMed  Google Scholar 

EASL. 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017, 67:370–398.

Li MH, Yi W, Zhang L, Lu Y, Lu HH, Shen G, Wu SL, Hao HX, Gao YJ, Chang M, et al. Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy. J Viral Hepat. 2019;26(Suppl 1):32–41.

Article  CAS  PubMed  Google Scholar 

Wu Y, Liu Y, Lu J, Cao Z, Jin Y, Ma L, Geng N, Ren S, Zheng Y, Shen C, Chen X. Durability of Interferon-induced Hepatitis B Surface Antigen Seroclearance. Clin Gastroenterol Hepatol. 2020;18:514–e516512.

Article  PubMed  Google Scholar 

Huang D, Wu D, Wang P, Wang Y, Yuan W, Hu D, Hu J, Wang Y, Tao R, Xiao F, et al. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB. J Hepatol. 2022;77:42–54.

Article  CAS  PubMed  Google Scholar 

Zeng QL, Yu ZJ, Shang J, Xu GH, Sun CY, Liu N, Li CX, Lv J, Liu YM, Liang HX, et al. Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers with Low Surface Antigen levels. Open Forum Infect Dis. 2020;7:ofaa208.

Article  PubMed  PubMed Central  Google Scholar 

Wu F, Wang Y, Cui D, Tian Y, Lu R, Liu C, Li M, Li Y, Gao N, Jiang Z et al. Short-term Peg-IFN α-2b Re-treatment Induced a high functional cure rate in patients with HBsAg recurrence after stopping Peg-IFN α-Based regimens. J Clin Med 2023, 12.

Cao Z, Liu Y, Ma L, Lu J, Jin Y, Ren S, He Z, Shen C, Chen X. A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha. Hepatology. 2017;66:1058–66.

Article  CAS  PubMed  Google Scholar 

Wu YL, Shen CL, Chen XY. Antiviral treatment for chronic hepatitis B: safety, effectiveness, and prognosis. World J Clin Cases. 2019;7:1784–94.

Article  PubMed  PubMed Central  Google Scholar 

Pan CQ, Li MH, Yi W, Zhang L, Lu Y, Hao HX, Wan G, Cao WH, Wang XY, Ran CP, et al. Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens. Liver Int. 2021;41:1498–508.

Article  CAS  PubMed  Google Scholar 

Song A, Wang X, Lu J, Jin Y, Ma L, Hu Z, Zheng Y, Shen C, Chen X. Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: a meta-analysis. J Viral Hepat. 2021;28:601–12.

Article  PubMed  PubMed Central  Google Scholar 

Jiang S, Cai M, Zhang Z, Qian C, Wang J, Li Z, Guo Q, Zhou H, Xin H, Cai W et al. The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance. Hum Vaccin Immunother 2023:2161254.

Liu Y, Ren S, Ma L, Lin X, Li H, Lu J et al. Clinical study of hepatitis B vaccine in achieving hepatitis B surface antibody seroconversion in patients with functional cure. Braz J Infect Dis, 2023:103703.

Wu ZQ, Tan L, Gan WQ, Mo ZS, Chen DB, Wang PP, Zhao QY, Xie DY, Gao ZL. The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α. Ann Transl Med. 2021;9:414.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu X, Shang Q, Chen X, Nie W, Zou Z, Huang A, Meng M, Jin L, Xu R, Zhang JY, et al. Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients. Cell Mol Immunol. 2015;12:309–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. J Hepatol. 2016;64:S71–83.

Article  CAS  PubMed  Google Scholar 

Salimzadeh L, Le Bert N, Dutertre CA, Gill US, Newell EW, Frey C, Hung M, Novikov N, Fletcher S, Kennedy PT, Bertoletti A. PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J Clin Invest. 2018;128:4573–87.

Article  PubMed  PubMed Central  Google Scholar 

Wu YC, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood. 2010;116:1070–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vásquez C, Franco MA, Angel J. Rapid Proliferation and differentiation of a subset of circulating IgM Memory B cells to a CpG/Cytokine stimulus in Vitro. PLoS ONE. 2015;10:e0139718.

Article  PubMed  PubMed Central  Google Scholar 

McHeyzer-Williams LJ, Milpied PJ, Okitsu SL, McHeyzer-Williams MG. Class-switched memory B cells remodel BCRs within secondary germinal centers. Nat Immunol. 2015;16:296–305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rinaldi S, Pallikkuth S, George VK, de Armas LR, Pahwa R, Sanchez CM, Pallin MF, Pan L, Cotugno N, Dickinson G, et al. Paradoxical aging in HIV: immune senescence of B cells is most prominent in young age. Aging. 2017;9:1307–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weinstein JS, Bertino SA, Hernandez SG, Poholek AC, Teplitzky TB, Nowyhed HN, Craft J. B cells in T follicular helper cell development and function: separable roles in delivery of ICOS ligand and antigen. J Immunol. 2014;192:3166–79.

Article  CAS  PubMed  Google Scholar 

Zhang L, Li H, Ren H, Hu P. Circulating PD-1(hi)CXCR5(+)CD4(+) T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-α therapy. Mol Immunol. 2018;103:270–8.

Article  CAS  PubMed  Google Scholar 

Liu Y, Hu X, Hu X, Yu L, Ji H, Li W, Cai Y, Cheng G, Jiang Y. T follicular helper cells improve the response of patients with chronic hepatitis B to interferon by promoting HBsAb production. J Gastroenterol. 2022;57:30–45.

Article  CAS  PubMed  Google Scholar 

Bentebibel SE, Khurana S, Schmitt N, Kurup P, Mueller C, Obermoser G, Palucka AK, Albrecht RA, Garcia-Sastre A, Golding H, Ueno H. ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination. Sci Rep. 2016;6:26494.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heit A, Schmitz F, Gerdts S, Flach B, Moore MS, Perkins JA, Robins HS, Aderem A, Spearman P, Tomaras GD, et al. Vaccination establishes clonal relatives of germinal center T cells in the blood of humans. J Exp Med. 2017;214:2139–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xing M, Feng Y, Yao J, Lv H, Chen Y, He H, Wang Z, Hu C, Lou X. Induction of peripheral blood T follicular helper cells expressing ICOS correlates with antibody response to hepatitis B vaccination. J Med Virol. 2020;92:62–70.

Article  CAS  PubMed  Google Scholar 

Chekol Abebe E, Asmamaw Dejenie T, Mengie Ayele T, Dagnew Baye N, Agegnehu Teshome A, Tilahun Muche Z. The Role of Regulatory B Cells in Health and diseases: a systemic review. J Inflamm Res. 2021;14:75–84.

Article  PubMed  PubMed Central  Google Scholar 

Sanaei MJ, Nahid-Samiei M, Abadi MSS, Arjmand MH, Ferns GA, Bashash D, Rahimian G, Bagheri N. New insights into regulatory B cells biology in viral, bacterial, and parasitic infections. Infect Genet Evol. 2021;89:104753.

Article  CAS  PubMed  Google Scholar 

Fu B, Wang D, Shen X, Guo C, Liu Y, Ye Y, Sun R, Li J, Tian Z, Wei H. Immunomodulation Induced during Interferon-α therapy impairs the Anti-HBV Immune Response through CD24(+)CD38(hi) B cells. Front Immunol. 2020;11:591269.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong Y, Zhao C, Zhao P, Wang M, Zhou G, Han F, Cui Y, Qian J, Zhang H, Xiong H, et al. Role of IL-10-Producing Regulatory B cells in Chronic Hepatitis B Virus infection. Dig Dis Sci. 2015;60:1308–14.

Article  CAS  PubMed  Google Scholar 

Körber N, Pohl L, Weinberger B, Grubeck-Loebenstein B, Wawer A, Knolle PA, Roggendorf H, Protzer U, Bauer T. Hepatitis B Vaccine Non-responders Show Higher frequencies of CD24(high)CD38(high) Regulatory B cells and lower levels of IL-10 expression compared to responders. Front Immunol. 2021;12:713351.

Article  PubMed  PubMed Central  Google Scholar 

Bolther M, Andersen KLD, Tolstrup M, Visvanathan K, Woolley I, Skinner N, Millen R, Warner N, Østergaard L, Jensen-Fangel S. Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine. Hum Vaccin Immunother. 2018;14:1483–8.

Article  PubMed  PubMed Central  Google Scholar